Tambi Jarmi

1 clinical trials · Sponsor

Record	Firm	Date
Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) (NCT04388761)	Tambi Jarmi	2020-09-01

Every clearance here is in the API, with alerts when new ones post.